Teradyne executive granted RSUs and stock options

Teradyne executive Shannon John Poulin, President, Semiconductor Test, reported new equity awards.

Rhea-AI Filing Summary

Teradyne executive Shannon John Poulin, President, Semiconductor Test, reported new equity awards. On February 4, 2026, he received 4,460 restricted stock units of common stock at no cost, bringing his directly held common shares to 17,235.5779.

The RSUs vest in four equal annual installments beginning on February 4, 2027. He also received a stock option grant for 3,937 shares of common stock with a $269.07 exercise price, vesting 25% per year over four years starting on February 4, 2027.

Insider Trade Summary

Grant/Award: 8,397 shares

Grant/Award 2 txns

Insider Poulin Shannon John

Role President, Semiconductor Test

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	3,937	$0.00	$0.00
Grant/Award	Common Stock	4,460	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 3,937 contracts (Direct); Common Stock — 17,235.5779 shares (Direct)

Footnotes (3)

1. F1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on February 4, 2027, the first anniversary of the grant.
2. F2. Includes 64.5779 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2025.
3. F3. The option vests 25% per year over four years beginning on February 4, 2027, the first anniversary of the grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Teradyne (TER) report for Shannon John Poulin?

Teradyne reported that executive Shannon John Poulin received grants of restricted stock units and stock options on February 4, 2026. These equity awards were reported as acquisitions at no cash cost to him, reflecting part of his compensation as President, Semiconductor Test.

How many Teradyne RSUs were granted to Shannon John Poulin in this Form 4?

Shannon John Poulin was granted 4,460 restricted stock units of Teradyne common stock. Each RSU equals one share of common stock and will be delivered as the awards vest over time according to the specified vesting schedule beginning in 2027.

What is the vesting schedule for Shannon John Poulin’s Teradyne RSU grant?

The 4,460 RSUs granted to Shannon John Poulin vest in four equal annual installments. Vesting begins on February 4, 2027, which is the first anniversary of the grant date, and continues each year until all units are fully vested.

What stock options did Shannon John Poulin receive from Teradyne and at what exercise price?

Shannon John Poulin received a stock option for 3,937 shares of Teradyne common stock with a $269.07 exercise price. The option was granted at no cost and gives him the right to buy shares at that fixed price if and when he chooses to exercise.

How do Shannon John Poulin’s Teradyne stock options vest over time?

The stock option for 3,937 shares vests 25% per year over four years. Vesting starts on February 4, 2027, the first anniversary of the grant date, and continues annually until the full option amount is vested and potentially exercisable.

How many Teradyne shares does Shannon John Poulin own after these transactions?

After the reported RSU grant, Shannon John Poulin beneficially owns 17,235.5779 shares of Teradyne common stock directly. This total includes 64.5779 shares acquired through the company’s Employee Stock Purchase Plan on December 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 05:08 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Poulin Shannon John

(Last) (First) (Middle)

C/O TERADYNE, INC.

600 RIVERPARK DRIVE

(Street)

NORTH READING MA 01864

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Semiconductor Test

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		A		4,460(1)	A	$0	17,235.5779(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$269.07	02/04/2026		A		3,937		(3)	02/04/2033	Common Stock	3,937	$0	3,937	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on February 4, 2027, the first anniversary of the grant.

2. Includes 64.5779 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2025.

3. The option vests 25% per year over four years beginning on February 4, 2027, the first anniversary of the grant.

	/s/ Ryan E. Driscoll, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.